Pharmacotherapy’s Scientific Editor concept, initiated in January 1992, has been a resounding success. Jerry Bauman, Pharm.D., FCCP, Gil Burckart, Pharm.D., FCCP, Barry Carter, Pharm.D., FCCP, Julie Johnson, Pharm.D., FCCP, and Mike Rybak, Pharm.D., MPH, FCCP, have all worked tirelessly in their roles as current Scientific Editors to increase the quality and quantity of the articles published in Pharmacotherapy. The Scientific Editors have assumed full editorial control (i.e., they select reviewers, assess reviewers’ comments, and make the accept/reject judgment) of papers in their areas of expertise. Furthermore, they have direct input to Pharmacotherapy’s Board of Directors to help guide the journal’s editorial direction and are responsible for the appointment of the journal’s Editorial Board members. We are proud to announce the appointment of a new Scientific Editor, Michael (Mick) Murray, Pharm.D., MPH. This esteemed scientist will assume his official responsibilities in the winter of 2010.
The Board of Directors and Scientific Editor Council review strategies on an ongoing basis to improve journal quality and impact in the field of pharmacotherapy. This year, the Scientific Editor Council recommended the initiatives below to further increase the impact of the journal. These initiatives were approved unanimously by the journal’s Board of Directors.
- Case reports are now published online only, starting with the December 2009 issue.
- “Key articles” (annotated bibliographies) are also now published online only, starting with the November 2009 issue.
The Scientific Editor Council and the Board of Directors are confident that these and other initiatives will lead to further increases in the influence and quality of the journal. We thank all of the ACCP members who have served the journal in so many capacities.